Closing system

Global Closed System Transfer Devices Market Report 2021-2026 – Emerging technologies for rapid detection tests to facilitate routine monitoring and safe handling of hazardous drugs


Dublin, Oct 13, 2021 (GLOBE NEWSWIRE) – The “Closed System Transfer Device Market by Type (Membrane to Membrane, Needle Free), Technology (Diaphragm Based, Compartmentalized, Filtration), Component, End User ( hospitals and clinics, Oncology centers) and Region – Global forecast to 2026 “has been added to ResearchAndMarkets.com offer.

The Closed System Transfer Device (CSTD) market is expected to reach $ 2,002 million by 2026, from $ 814 million in 2021, at a CAGR of 19.7%.

The growth of the market is largely due to the harmful effects (persistent role) of cytotoxic drugs, the increasing incidence of cancer, the growing number of oncology drug approvals, and improved regulatory guidelines for the safe handling of dangerous drugs. .

The color-to-color alignment system is expected to experience the fastest growth during the forecast period.

On the basis of the locking mechanism, the market is segmented into Luer-lock systems, color-to-color alignment systems, click-to-lock systems and push-to-turn systems. In 2020, the Luer-lock systems segment accounted for the highest 32.5% share of the market. This segment is expected to reach $ 636.8 million by 2026 from $ 264.1 million in 2021, at a CAGR of 19.2%. However, the color-to-color alignment systems segment is expected to grow at the highest rate due to its superior efficiency due to pressure equalization mechanisms and low cost.

Membrane to membrane systems are expected to experience the fastest growth during the forecast period.

Based on device type, the market is segmented into membrane-to-membrane systems and needle-free systems. In 2020, the membrane-to-membrane systems segment accounted for the largest 71.01% share of the CSTD market. This segment is expected to reach $ 1,488.9 million by 2026 compared to $ 583.1 million in 2021, at a CAGR of 20.6%. The significant share and strong growth of this segment is attributed to their ease of use and lower risk of contamination associated with double membrane containment systems.

The membrane devices segment accounted for the largest share of the closed system transfer device market in 2020.

Based on the technology, the CSTD market is segmented into diaphragm devices, compartmentalized devices, and air purification / filtration devices. In 2020, the diaphragm devices segment accounted for the largest 43.63% market share. This segment is expected to reach $ 829.4 million by 2026 from $ 353.1 million in 2021, at a CAGR of 18.6%.

The significant share of this segment is mainly due to the ease of use and security provided by these devices. The compartmentalized devices segment is expected to grow at the highest CAGR of 23.8% during the forecast period due to their lower cost.

The vial access devices segment accounted for the largest share of the closed system transfer device market in 2020.

On the basis of components, the CSTD market is segmented into vial access devices, syringe safety devices, bag / line access devices and accessories. In 2020, the vial access devices segment accounted for the largest market share of 33.08%. The significant share of this segment is mainly due to the increasing adoption of CSTD products and vial access devices by oncology nurses to transfer hazardous drugs from the wrapped vials to the infusion bag or the patient.

Hospitals and clinics accounted for the largest share of the closed system transfer device market in 2020.

Based on end users, the market is segmented into hospitals and clinics, cancer centers, and other end users. In 2020, hospitals and clinics accounted for the largest 84.41% share of the CSTD market. The significant share and strong growth of this segment are mainly due to the strong financial capacities of hospitals for the purchase of high-priced CSTDs, the large pool of cancer patients and the need to comply with regulatory guidelines.

North America accounted for the largest share of the closed system transfer device market in 2020.

In 2020, North America accounted for the largest share of the market. The market in North America is characterized by easy access to advanced technologies, high awareness of CSTD among oncologists, nurses and pharmacists, the presence of many CSTD manufacturing players in this region and the incidence and the high prevalence of cancer.

However, the APAC market is expected to experience the highest CAGR of 22.1% during the forecast period. The growing incidence of cancer, the growing demand for better health services in developing economies, and the growing attention of international players in emerging markets such as India and China are driving the growth of the Asia market. Peaceful.

Competitive landscape

The major players in the closed system transfer device market are Becton, Dickinson and Company (US), ICU Medical (US), Equashield. (USA), B. Braun Melsungen AG (Germany), Corvida Medical (USA), Yukon Medical (USA), JMS (USA), CODAN Medizinische Gerate (Germany), Baxter International (USA) United States) and VICTUS (United States).

Premium previews

  • Rising Cancer Incidence Drives Growth In Closed System Transfer Device Market
  • Membrane devices accounted for the largest share of the APAC closed system transfer device market in 2020
  • North America to Dominate the Market Throughout the Forecast Period
  • China to grow at highest CAGR during forecast period
  • Developing markets will register higher growth during the forecast period

Closed System Transfer Devices Market Dynamics

Conductors

  • Increased incidence of cancer
  • The growing number of drug approvals in oncology
  • Growing use of cstds to combat the harmful effects of cytotoxic or antineoplastic drugs
  • Growing focus on the implementation of occupational health and safety standards

Constraints

  • High cost of implementing Cstds and lack of reimbursement
  • Lack of compliance with regulatory guidelines in developing countries

Opportunities

  • Growing application of Cstd in other therapeutic areas
  • Growing adoption in emerging economies due to rising healthcare spending

Challenges

  • Gaps with existing Cstds
  • Low awareness of nurses to cstds

Industry trends

  • Automated composition of hazardous drugs using robotic systems
  • Emerging technologies for rapid detection tests to facilitate routine monitoring and safe handling of hazardous drugs

Companies mentioned

  • Advcare Medical
  • B. Braun Melsungen
  • Baxter International
  • Becton, Dickinson and company
  • Caragene
  • Cardinal Health
  • Codan Medizinische Gerate
  • Corning Incorporated
  • Corvida Medical
  • Edge Pharma
  • Elcam Medical
  • Epic medical
  • Equashield
  • Medical Eraser
  • Intensive medical care
  • Insung Medical
  • JMS
  • Needle-free society
  • Practice
  • Simplivia Health
  • Terumo Company
  • Victus
  • Vygon Sa
  • Western Pharmaceutical Services
  • Yukon Medicine

For more information on this report, visit https://www.researchandmarkets.com/r/tz6zpk

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Main logo


Leave a Reply

Your email address will not be published.